Menu
Back to Journals » OncoTargets and Therapy » Volume 13
RETRACTED ARTICLE: LncRNA LINC01116 Contributes to Cisplatin Resistance in Lung Adenocarcinoma
Authors Wang J , Gao J, Chen Q, Zou W, Yang F , Wei C, Wang Z
Received 6 January 2020
Accepted for publication 11 August 2020
Published 22 September 2020 Volume 2020:13 Pages 9333—9347
DOI https://doi.org/10.2147/OTT.S244879
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 3
Editor who approved publication: Dr Tohru Yamada
This paper has been retracted.
Wang J, Gao J, Chen Q, et al. Onco Targets Ther. 2020;13:9333–9347.
At the authors request, we the Editor and Publisher of OncoTargets and Therapy are retracting the published article. Concerns were raised to the authors attention regarding the duplication of images in Figures 2 and 5. Specifically,
- Images from Figure 2E, Invasion, si-LINC1116 1# and si-LINC01116 2#, were duplicated.
- Images from Figure 5E, Migration, Empty vector and Invasion, Empty vector and pcDNA-LINC0116 were duplicated.
The authors explained that errors had been made during the preparation of the figures, but no original data was provided to the journal. As verifying the validity of published work is core to the integrity of the scholarly record, the authors requested to retract the article. The editor agreed with this decision.
We have been informed in our decision-making by our editorial policies and the COPE guidelines.
The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.
© 2020 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.